GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Purchase Of Investment

ImmunityBio (STU:26CA) Purchase Of Investment : €-54.05 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Purchase Of Investment?

ImmunityBio's purchase of investment for the three months ended in Mar. 2024 was €-44.49 Mil. It means ImmunityBio spent €44.49 Mil on purchasing investments. ImmunityBio's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €-54.05 Mil.

Compared with last quarter (€-0.15 Mil in Dec. 2023 ), ImmunityBio spent more money on purchasing investments in Mar. 2024 (€-44.49 Mil).


ImmunityBio Purchase Of Investment Historical Data

The historical data trend for ImmunityBio's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Purchase Of Investment Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
-78.47 -75.43 -125.45 -32.39 -9.50

ImmunityBio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -0.07 -9.33 -0.15 -44.49

ImmunityBio Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-54.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunityBio Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of ImmunityBio's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunityBio (STU:26CA) Business Description

Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.

ImmunityBio (STU:26CA) Headlines

No Headlines